Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Connectez-vous et complétez votre Funding Passport pour voir si vous êtes admissible — un verdict transparent, fondé sur des règles, pas une boîte noire.
Se connecterÀ propos de cette possibilité
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Documents requis
La source officielle n'indique pas de documents précis ici — vérifiez les exigences avant de postuler.
Source et traçabilité de vérification
- Source officielle
- U.S. Federal Government (Grants.gov) ↗
- Première collecte
- 20 novembre 2026
- Dernière vérification
- 20 novembre 2026
- Empreinte du contenu
87a49fcacd600b05…